|
Mechanismadrenergic receptor agonists |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.China |
First Approval Date01 Jan 1985 |
100 Clinical Results associated with Jiangsu Langou Pharmaceutical Co. Ltd.
0 Patents (Medical) associated with Jiangsu Langou Pharmaceutical Co. Ltd.
100 Deals associated with Jiangsu Langou Pharmaceutical Co. Ltd.
100 Translational Medicine associated with Jiangsu Langou Pharmaceutical Co. Ltd.